{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T18:07:39Z","timestamp":1775066859007,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T00:00:00Z","timestamp":1730332800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T00:00:00Z","timestamp":1730332800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Project supported by the Sichuan Natural Science Foundation","award":["2023NSFSC0331"],"award-info":[{"award-number":["2023NSFSC0331"]}]},{"name":"Project supported by the Sichuan Natural Science Foundation","award":["2023NSFSC0331"],"award-info":[{"award-number":["2023NSFSC0331"]}]},{"name":"Project supported by the Sichuan Natural Science Foundation","award":["2023NSFSC0331"],"award-info":[{"award-number":["2023NSFSC0331"]}]},{"name":"Project supported by the Sichuan Natural Science Foundation","award":["2023NSFSC0331"],"award-info":[{"award-number":["2023NSFSC0331"]}]},{"name":"Project supported by the Sichuan Natural Science Foundation","award":["2023NSFSC0331"],"award-info":[{"award-number":["2023NSFSC0331"]}]},{"name":"Project supported by the Sichuan Natural Science Foundation","award":["2023NSFSC0331"],"award-info":[{"award-number":["2023NSFSC0331"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-76724-z","type":"journal-article","created":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T02:02:18Z","timestamp":1730340138000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Silencing CCT3 induces ferroptosis through the NOD1-NF-\u03baB signaling pathway in bladder cancer"],"prefix":"10.1038","volume":"14","author":[{"given":"Jianlin","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yizhao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shize","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runhua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,31]]},"reference":[{"issue":"1","key":"76724_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel, R. L., Giaquinto, A. N. & Jemal, A. Cancer statistics, 2024. CA Cancer J. Clin. 74 (1), 12\u201349 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"76724_CR2","doi-asserted-by":"publisher","first-page":"e076743","DOI":"10.1136\/bmj-2023-076743","volume":"384","author":"A Lopez-Beltran","year":"2024","unstructured":"Lopez-Beltran, A. et al. Advances in diagnosis and treatment of bladder cancer. BMJ 384, e076743 (2024).","journal-title":"BMJ"},{"issue":"1","key":"76724_CR3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","volume":"9","author":"L Dyrskj\u00f8t","year":"2023","unstructured":"Dyrskj\u00f8t, L. et al. Bladder cancer. Nat. Rev. Dis. Primers. 9 (1), 58 (2023).","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"3","key":"76724_CR4","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.eururo.2023.11.008","volume":"85","author":"W Beckabir","year":"2024","unstructured":"Beckabir, W. et al. Spatial relationships in the tumor microenvironment demonstrate association with pathologic response to neoadjuvant chemoimmunotherapy in muscle-invasive bladder cancer. Eur. Urol. 85(3), 242\u2013253 (2024).","journal-title":"Eur. Urol."},{"issue":"23","key":"76724_CR5","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.21037\/atm-20-2108","volume":"8","author":"Y Zang","year":"2020","unstructured":"Zang, Y. et al. An overview of patients with urothelial bladder cancer over the past two decades: a Surveillance, Epidemiology, and end results (SEER) study. Ann. Transl Med. 8 (23), 1587 (2020).","journal-title":"Ann. Transl Med."},{"issue":"7","key":"76724_CR6","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","volume":"22","author":"G Lei","year":"2022","unstructured":"Lei, G., Zhuang, L. & Gan, B. Targeting ferroptosis as a vulnerability in cancer. Nat. Rev. Cancer. 22 (7), 381\u2013396 (2022).","journal-title":"Nat. Rev. Cancer"},{"key":"76724_CR7","doi-asserted-by":"publisher","first-page":"154999","DOI":"10.1016\/j.phymed.2023.154999","volume":"119","author":"Q Yu","year":"2023","unstructured":"Yu, Q. et al. EGCG attenuated acute myocardial infarction by inhibiting ferroptosis via miR-450b-5p\/ACSL4 axis. Phytomedicine. 119, 154999 (2023).","journal-title":"Phytomedicine"},{"issue":"1","key":"76724_CR8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","volume":"21","author":"C Zhang","year":"2022","unstructured":"Zhang, C. et al. Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Mol. Cancer. 21 (1), 47 (2022).","journal-title":"Mol. Cancer"},{"issue":"9","key":"76724_CR9","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.molmed.2021.06.014","volume":"27","author":"H Xu","year":"2021","unstructured":"Xu, H. et al. Ferroptosis in the tumor microenvironment: perspectives for immunotherapy. Trends Mol. Med. 27 (9), 856\u2013867 (2021).","journal-title":"Trends Mol. Med."},{"key":"76724_CR10","doi-asserted-by":"publisher","first-page":"215854","DOI":"10.1016\/j.canlet.2022.215854","volume":"546","author":"J Lee","year":"2022","unstructured":"Lee, J. & Roh, J. L. Induction of ferroptosis in head and neck cancer: a novel bridgehead for fighting cancer resilience. Cancer Lett. 546, 215854 (2022).","journal-title":"Cancer Lett."},{"key":"76724_CR11","doi-asserted-by":"publisher","first-page":"1043283","DOI":"10.3389\/fphar.2022.1043283","volume":"13","author":"F Zeng","year":"2022","unstructured":"Zeng, F. et al. Ferroptosis: a new therapeutic target for bladder cancer. Front. Pharmacol. 13, 1043283 (2022).","journal-title":"Front. Pharmacol."},{"issue":"5","key":"76724_CR12","doi-asserted-by":"publisher","first-page":"e17855","DOI":"10.1111\/jcmm.17855","volume":"28","author":"P Jiang","year":"2023","unstructured":"Jiang, P. et al. FLRT2 suppresses bladder cancer progression through inducing ferroptosis. J. Cell. Mol. Med. 28 (5), e17855 (2023).","journal-title":"J. Cell. Mol. Med."},{"issue":"11","key":"76724_CR13","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/s41419-021-04306-2","volume":"12","author":"Y Sun","year":"2021","unstructured":"Sun, Y. et al. Fin56-induced ferroptosis is supported by autophagy-mediated GPX4 degradation and functions synergistically with mTOR inhibition to kill bladder cancer cells. Cell. Death Dis. 12 (11), 1028 (2021).","journal-title":"Cell. Death Dis."},{"key":"76724_CR14","doi-asserted-by":"publisher","first-page":"961733","DOI":"10.3389\/fonc.2022.961733","volume":"12","author":"W Liu","year":"2022","unstructured":"Liu, W. et al. Current understanding on the role of CCT3 in cancer research. Front. Oncol. 12, 961733 (2022).","journal-title":"Front. Oncol."},{"key":"76724_CR15","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.freeradbiomed.2021.01.016","volume":"165","author":"E Temiz","year":"2021","unstructured":"Temiz, E., Koyuncu, \u0130. & Sahin, E. CCT3 suppression prompts apoptotic machinery through oxidative stress and energy deprivation in breast and prostate cancers. Free Radic Biol. Med. 165, 88\u201399 (2021).","journal-title":"Free Radic Biol. Med."},{"key":"76724_CR16","doi-asserted-by":"crossref","unstructured":"Dou, L. & Zhang, X. Upregulation of CCT3 promotes cervical cancer progression through FN1. Mol. Med. Rep. 24\u00a0(6),\u00a012496 (2021).","DOI":"10.3892\/mmr.2021.12496"},{"key":"76724_CR17","doi-asserted-by":"crossref","unstructured":"Chen, S. et al. Suppression of CCT3 inhibits tumor progression by impairing ATP production and cytoplasmic translation in lung adenocarcinoma. Int. J. Mol. Sci. 23\u00a0(7),\u00a03983 (2022).","DOI":"10.3390\/ijms23073983"},{"issue":"1","key":"76724_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12860-022-00424-7","volume":"23","author":"K Wang","year":"2022","unstructured":"Wang, K. et al. Upregulation of CCT3 predicts poor prognosis and promotes cell proliferation via inhibition of ferroptosis and activation of AKT signaling in lung adenocarcinoma. BMC Mol. Cell. Biol. 23 (1), 25 (2022).","journal-title":"BMC Mol. Cell. Biol."},{"issue":"4","key":"76724_CR19","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1007\/s12031-019-01466-x","volume":"70","author":"S Wasmuth","year":"2020","unstructured":"Wasmuth, S. et al. Phenotypic Differences in Primary Murine Microglia Treated with NOD1, NOD2, and NOD1\/2 agonists. J. Mol. Neurosci. 70 (4), 600\u2013609 (2020).","journal-title":"J. Mol. Neurosci."},{"issue":"2","key":"76724_CR20","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.gendis.2023.03.031","volume":"11","author":"X Wang","year":"2024","unstructured":"Wang, X. et al. Echinatin inhibits tumor growth and synergizes with chemotherapeutic agents against human bladder cancer cells by activating p38 and suppressing Wnt\/\u03b2-catenin pathways. Genes Dis. 11 (2), 1050\u20131065 (2024).","journal-title":"Genes Dis."},{"issue":"10364","key":"76724_CR21","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1016\/S0140-6736(22)01188-6","volume":"400","author":"E Comp\u00e9rat","year":"2022","unstructured":"Comp\u00e9rat, E. et al. Current best practice for bladder cancer: a narrative review of diagnostics and treatments. Lancet. 400 (10364), 1712\u20131721 (2022).","journal-title":"Lancet"},{"issue":"43","key":"76724_CR22","doi-asserted-by":"publisher","first-page":"8906","DOI":"10.1039\/D1TB01654G","volume":"9","author":"Q Guan","year":"2021","unstructured":"Guan, Q., Zhou, L. L. & Dong, Y. B. Ferroptosis in cancer therapeutics: a materials chemistry perspective. J. Mater. Chem. B. 9 (43), 8906\u20138936 (2021).","journal-title":"J. Mater. Chem. B"},{"issue":"18","key":"76724_CR23","doi-asserted-by":"publisher","first-page":"16885","DOI":"10.1007\/s00432-023-05266-0","volume":"149","author":"J Liu","year":"2023","unstructured":"Liu, J. et al. Identifying possible hub genes and biological mechanisms shared between bladder cancer and inflammatory bowel disease using machine learning and integrated bioinformatics. J. Cancer Res. Clin. Oncol. 149 (18), 16885\u201316904 (2023).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"76724_CR24","doi-asserted-by":"crossref","unstructured":"Nedjadi, T. et al. Identification of SPP1 as a prognostic biomarker and immune cells modulator in urothelial bladder cancer: a bioinformatics analysis. Cancers (Basel) 15\u00a0(23),\u00a05704 (2023).","DOI":"10.3390\/cancers15235704"},{"key":"76724_CR25","doi-asserted-by":"crossref","unstructured":"Fan, Y. et al. PLC\u03b5 promotes the Warburg effect and tumorigenesis through AKT\/GSK3\u03b2\/Cdc25a in bladder cancer. Biotechnol. Genet. Eng. Rev. 40\u00a0(3), 2155\u20132169 (2024).","DOI":"10.1080\/02648725.2023.2199188"},{"key":"76724_CR26","doi-asserted-by":"publisher","first-page":"110836","DOI":"10.1016\/j.cellsig.2023.110836","volume":"110","author":"Y Hao","year":"2023","unstructured":"Hao, Y. et al. MicroRNA-30c-5p arrests bladder cancer G2\/M phase and suppresses its progression by targeting PRC1-mediated blocking of CDK1\/Cyclin B1 axis. Cell. Signal. 110, 110836 (2023).","journal-title":"Cell. Signal."},{"key":"76724_CR27","doi-asserted-by":"publisher","first-page":"101942","DOI":"10.1016\/j.tranon.2024.101942","volume":"44","author":"Y Wu","year":"2024","unstructured":"Wu, Y. et al. Identification of a cisplatin resistant-based prognostic immune related gene signature in MIBC. Transl Oncol. 44, 101942 (2024).","journal-title":"Transl Oncol."},{"key":"76724_CR28","doi-asserted-by":"publisher","first-page":"100081","DOI":"10.1016\/j.clinsp.2022.100081","volume":"77","author":"J Min","year":"2022","unstructured":"Min, J. et al. Long non-coding RNA SNHG1 promotes bladder cancer progression by upregulating EZH2 and repressing KLF2 transcription. Clin. (Sao Paulo). 77, 100081 (2022).","journal-title":"Clin. (Sao Paulo)"},{"issue":"9","key":"76724_CR29","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/s41419-019-1894-5","volume":"10","author":"Y Liu","year":"2019","unstructured":"Liu, Y. et al. CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. Cell. Death Dis. 10 (9), 644 (2019).","journal-title":"Cell. Death Dis."},{"issue":"1","key":"76724_CR30","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s13046-024-03169-7","volume":"43","author":"H Zhu","year":"2024","unstructured":"Zhu, H. et al. CCT3\/ACTN4\/TFRC axis protects hepatocellular carcinoma cells from ferroptosis by inhibiting iron endocytosis. J. Exp. Clin. Cancer Res. 43 (1), 245 (2024).","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"14","key":"76724_CR31","doi-asserted-by":"publisher","first-page":"5459","DOI":"10.7150\/ijbs.74546","volume":"18","author":"L Shen","year":"2022","unstructured":"Shen, L. et al. PHGDH inhibits ferroptosis and promotes malignant progression by upregulating SLC7A11 in bladder Cancer. Int. J. Biol. Sci. 18 (14), 5459\u20135474 (2022).","journal-title":"Int. J. Biol. Sci."},{"key":"76724_CR32","doi-asserted-by":"publisher","first-page":"147974","DOI":"10.1016\/j.gene.2023.147974","volume":"894","author":"Y Cao","year":"2024","unstructured":"Cao, Y. et al. LUCAT1 inhibits ferroptosis in bladder cancer by regulating the mRNA stability of STAT3. Gene. 894, 147974 (2024).","journal-title":"Gene"},{"issue":"12","key":"76724_CR33","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/s41419-023-06333-7","volume":"14","author":"T Liu","year":"2023","unstructured":"Liu, T. et al. ALOX5 deficiency contributes to bladder cancer progression by mediating ferroptosis escape. Cell. Death Dis. 14 (12), 800 (2023).","journal-title":"Cell. Death Dis."},{"issue":"7","key":"76724_CR34","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1002\/mc.23533","volume":"62","author":"Y Luo","year":"2023","unstructured":"Luo, Y. et al. PCBP1 protects bladder cancer cells from mitochondria injury and ferroptosis by inducing LACTB mRNA degradation. Mol. Carcinog. 62 (7), 907\u2013919 (2023).","journal-title":"Mol. Carcinog."},{"issue":"6","key":"76724_CR35","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1093\/procel\/pwae005","volume":"15","author":"W Ma","year":"2024","unstructured":"Ma, W. et al. Microbiota enterotoxigenic Bacteroides fragilis-secreted BFT-1 promotes breast cancer cell stemness and chemoresistance through its functional receptor NOD1. Protein Cell. 15 (6), 419\u2013440 (2024).","journal-title":"Protein Cell."},{"issue":"1","key":"76724_CR36","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13578-024-01210-y","volume":"14","author":"J Zhuang","year":"2024","unstructured":"Zhuang, J. et al. Membrane-associated RING-CH 7 inhibits stem-like capacities of bladder cancer cells by interacting with nucleotide-binding oligomerization domain containing 1. Cell. Biosci. 14 (1), 32 (2024).","journal-title":"Cell. Biosci."},{"issue":"4","key":"76724_CR37","doi-asserted-by":"publisher","first-page":"108677","DOI":"10.1016\/j.celrep.2020.108677","volume":"34","author":"C Maisonneuve","year":"2021","unstructured":"Maisonneuve, C. et al. Nod1 promotes colorectal carcinogenesis by regulating the immunosuppressive functions of tumor-infiltrating myeloid cells. Cell. Rep. 34 (4), 108677 (2021).","journal-title":"Cell. Rep."},{"issue":"2","key":"76724_CR38","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00418-021-02055-z","volume":"157","author":"W Zhang","year":"2022","unstructured":"Zhang, W. & Wang, Y. Activation of RIPK2-mediated NOD1 signaling promotes proliferation and invasion of ovarian cancer cells via NF-\u03baB pathway. Histochem. Cell. Biol. 157 (2), 173\u2013182 (2022).","journal-title":"Histochem. Cell. Biol."},{"key":"76724_CR39","doi-asserted-by":"publisher","first-page":"1136067","DOI":"10.3389\/fendo.2023.1136067","volume":"14","author":"X Shi","year":"2023","unstructured":"Shi, X. et al. Eugenol modulates the NOD1-NF-\u03baB signaling pathway via targeting NF-\u03baB protein in triple-negative breast cancer cells. Front. Endocrinol. (Lausanne). 14, 1136067 (2023).","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"76724_CR40","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12916-022-02248-w","volume":"20","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. Upregulation of NOD1 and NOD2 contribute to cancer progression through the positive regulation of tumorigenicity and metastasis in human squamous cervical cancer. BMC Med. 20 (1), 55 (2022).","journal-title":"BMC Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76724-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76724-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76724-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T02:02:25Z","timestamp":1730340145000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76724-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,31]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["76724"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-76724-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,31]]},"assertion":[{"value":"28 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experiments conformed to the Guide for the Care and Use of Laboratory Animals. Animal study has been approved by the Animal Ethics Committee of Sichuan Provincial People\u2019s Hospital.\u00a0All methods are reported in accordance with ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods are reported in accordance with ARRIVE guidelines.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26188"}}